2020 Global Cancer Diagnostics Market: USA, Europe, Japan--Supplier Shares and Strategies by Test, Volume and Sales Segment Forecasts, Emerging Tumor Markers, Technologies and Instrumentation

2020 Global Cancer Diagnostics Market: USA, Europe, Japan--Supplier Shares and Strategies by Test, Volume and Sales Segment Forecasts, Emerging Tumor Markers, Technologies and Instrumentation

  • March 2020 •
  • 1200 pages •
  • Report ID: 5873530 •
  • Format: PDF
2020 Global Cancer Diagnostics Market: USA, Europe, Japan--Supplier Shares and Strategies by Test, Volume and Sales Segment Forecasts, Emerging Tumor Markers, Technologies and Instrumentation

This new report is a study of the major business opportunities emerging in the global cancer diagnostics market during the next five years. The report examines trends in the U.S., Europe and Japan; reviews current and emerging assays; analyzes potential applications of new diagnostic technologies; forecasts sales of major tumor markers by country and market segment; profiles leading players and potential market entrants; and identifies specific business opportunities for suppliers.

Companies Profiled
Company Assessments

- Abbott
- Agilent Technologies
- Applied Gene Technologies
- Arca Biopharma
- Beckman Coulter/Danaher
- Becton Dickinson
- bioMerieux
- Bio-Rad
- CellSearch
- Cepheid
- Clinical Genomics
- Decode Genetics
- DiaSorin
- Diazyme
- Eiken Chemical
- Elitech Group
- Enzo Biochem
- Epigenomics
- Exact Sciences
- Fujirebio
- Guided Therapeutics
- Hologic
- Janssen Diagnostics
- Kyowa Medex
- Leica Biosystems
- Myriad Genetics
- OncoLab
- Ortho-Clinical Diagnostics
- Panacea Pharmaceuticals
- PerkinElmer
- Polymedco
- Qiagen
- Quest Diagnostics
- Roche
- Scienion
- Sequenom
- Siemens Healthineers
- Takara Bio
- Theradiag
- Thermo Fisher
- Tosoh
- Vermillion
- Wako Pure Chemicals